Alpha-Momorcharin Inhibits Proinflammatory Cytokine Expression by M1 Macrophages but Not Anti-Inflammatory Cytokine Expression by M2 Macrophages
Kejun Peng,Nianhua Deng,Yao Meng,Qianchuan He,Hao Meng,Ting Luo,Yanru Wei,Yue Kang,Xiaodong Zhou,Fubing Shen
DOI: https://doi.org/10.2147/JIR.S372306
IF: 4.5
2022-08-25
Journal of Inflammation Research
Abstract:Kejun Peng, 1, * Nianhua Deng, 1, * Yao Meng, 1, * Qianchuan He, 2 Hao Meng, 3 Ting Luo, 4 Yanru Wei, 1 Yue Kang, 1 Xiaodong Zhou, 1 Fubing Shen 1 1 School of Laboratory Medicine, Chengdu Medical College, Chengdu, People's Republic of China; 2 Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA; 3 PKU-IDG/McGovern Institute for Brain Research, Peking-Tsinghua Center for Life Sciences, Peking University School of Life Sciences, Beijing, People's Republic of China; 4 Wuhan Corebiolab Co., Ltd, Wuhan, People's Republic of China *These authors contributed equally to this work Correspondence: Fubing Shen, School of Laboratory Medicine, Chengdu Medical College, No. 783 Xindu Avenue, Xindu District, Chengdu, 610500, People's Republic of China, Tel +86 28 62739522, Email Background: Alpha-momorcharin (α-MMC) is a natural medicine derived from bitter melon and has been found to exert immunomodulatory effects. Our previous study indicated that α-MMC can regulate cytokine release from monocytes, but it remains unknown about its regulatory effect on different types of cytokines, such as inflammatory cytokines or anti-inflammatory cytokines. Methods: LPS-induced M1-type macrophages model and IL-4-induced M2-type macrophages model were established, and the expression of proinflammatory cytokines and anti-inflammatory cytokines were assessed by ELISA after α-MMC was administered. Then, a LPS-induced acute pneumonia mouse model was established, the proinflammatory cytokines levels and inflammatory lesions in lung tissues were examined by ELISA or H&E staining. Furthermore, omics screening analysis and Western blotting verification were performed on TLR4 and JAK1-STAT6 signalling pathway-related proteins to elucidate the regulatory mechanism of α-MMC in those M1 macrophages and M2 macrophages. Results: At a noncytotoxic dose of 0.3 μg/mL, α-MMC significantly inhibited the LPS-induced expression of inflammatory cytokines, such as TNF-α, IL-1β, IL-6, IL-8, MIP-1α and MCP-1, by M1 macrophages in a time-dependent manner, but α-MMC did not inhibit the IL-4-induced synthesis of anti-inflammatory cytokines, such as IL-10, IL-1RA, EGF, VEGF, TGF-β and CCL22, by M2 macrophages. Moreover, α-MMC also inhibited inflammatory cytokine expression in an LPS-induced acute pneumonia mouse model and alleviated inflammation in lung tissues. Furthermore, omics screening and Western blotting analysis confirmed that α-MMC inhibited TAK1/p-TAK1 and subsequently blocked the downstream MAPK and NF-κB pathways, thus inhibiting the LPS-induced inflammatory cytokine expression. Conclusion: Our results reveal that α-MMC inhibits proinflammatory cytokine expression by M1 macrophages but not anti-inflammatory cytokine expression by M2 macrophages. The efficacy of α-MMC in selectively inhibiting proinflammatory cytokine expression renders it particularly suitable for the treatment of severe inflammation and autoimmune diseases characterized by cytokine storms. Keywords: α-MMC, M1 macrophage, proinflammatory cytokine, TLR4-NF-κB/MAPK Alpha-momorcharin (α-MMC) is a type I ribosome-inactivating protein (RIP) that is purified from the seeds of Momordica charantia . 1,2 In addition to its antitumor and antiviral effects, α-MMC also exerts immunomodulatory effects. 3 It has been found that α-MMC can significantly inhibit macrophage activity, such as macrophage cytostatic and phagocytic activities. A single injection of a nontoxic dose of α-MMC into mice significantly suppressed delayed-type hypersensitivity responses as well as the production of humoral antibodies against sheep red blood cells, and the thioglycolate-induced migration of macrophage migration was inhibited in vivo. Recently, we also found that α-MMC can regulate cytokine expression in monocytes in vivo and in vitro. 4–6 α-MMC exerted a significant effect on the induction of apoptosis and release of cytokines by THP-1 cells, but it exerted no effect on normal WIL2-s B cells and H9 T cells. Specifically, at a noncytotoxic dose, α-MMC regulates THP-1 cells by inhibiting IL-1β, IL-2, IL-8, IL-9, IL-12, MIP-1α/β, MCP-1 and TNF-α expression and enhancing IL-1rα and RANTES expression, resulting in the inhibition of cellular immune function. The regulation of cytokine expression in the THP-1 monocyte cell line mainly results in an immunosuppressive effect, and the regulation of THP-1 cell cytokine production may be the initial step in the immunosuppressive effect of α-MMC. However, in THP-1 cells, the primary effects of α-MMC treatment are the promotion of I -Abstract Truncated-
immunology